Judges Scientific encouraged by start to 2025 after "difficult" year

(Alliance News) - Judges Scientific PLC on Monday said it expects 2024 earnings in line with ...

Alliance News 20 January, 2025 | 9:09AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Judges Scientific PLC on Monday said it expects 2024 earnings in line with market expectations after mixed trading in 2024.

The London-based investor in scientific instrument sector said 2024 had been a "difficult" year for the group, with a challenging trading environment resulting in mixed trading.

Headwinds included a large reduction in orders from China, together with a general weakness in order intake and some customers delaying orders and deliveries.

Organic order intake, including a Geotek coring contract, was up 7% versus 2023. Excluding this order, the organic order intake finished up 2.2% versus 2023.

But organic revenue was down 5.8% from 2023, and down 0.7% excluding coring.

Judges Scientific said it remains confident in the long-term growth drivers of the business and expects adjusted earnings per share for 2024 to be in line with current market expectations.

A company compiled consensus put expectations for adjusted EPS in the year to December 31 at 276.8 pence.

The current year is starting more encouragingly, the firm said, with Geotek's coring expedition having commenced and a number of the deferred projects from 2024 now anticipated to contribute to first half earnings.

Shares in Judges Scientific were 1.1% higher at 7,440.00 pence each in London on Monday morning.

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Judges Scientific PLC 7,480.00 GBX -2.09 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures